Page last updated: 2024-08-23

bezafibrate and Sleep Wake Disorders

bezafibrate has been researched along with Sleep Wake Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, N; Kudo, T; Oishi, K; Shibata, S; Shirai, H1

Other Studies

1 other study(ies) available for bezafibrate and Sleep Wake Disorders

ArticleYear
PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.
    Biochemical and biophysical research communications, 2007, Jun-08, Volume: 357, Issue:3

    Topics: Animals; ARNTL Transcription Factors; Basic Helix-Loop-Helix Transcription Factors; Behavior, Animal; Bezafibrate; Blotting, Northern; Cell Cycle Proteins; Circadian Rhythm; DNA-Binding Proteins; Drinking Behavior; Gene Expression Regulation; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred ICR; Motor Activity; Nuclear Proteins; Nuclear Receptor Subfamily 1, Group D, Member 1; Period Circadian Proteins; PPAR alpha; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sleep Wake Disorders; Time Factors; Transcription Factors

2007